Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Operating expenses:
Research and development expenses	$ 6,099,580	$ 830,744
General and administrative expenses	10,981,765	2,788,016
Impairment expense IPRD	2,974,000	0
Lease termination costs	979,273	0
Depreciation and amortization	0	27,426
Total operating expenses	21,034,618	3,646,186
Loss from operations	(21,034,618)	(3,646,186)
Other income (expense):
Gain on bargain purchase upon merger	13,334,568	0
Interest income	353,490	0
Interest expense	(33,559)	(3,595)
Other	0	(900)
Loss on extinguishment of debt	0	(185,800)
Loss before income taxes	(7,380,119)	(3,836,481)
Income taxes (benefit)	(381,513)	0
Net loss	(6,998,606)	(3,836,481)
Comprehensive loss	$ (6,998,617)	$ (3,836,470)
Net loss per share, basic and diluted (in dollars per share)	$ 1.44	$ 1.15
Weighted average common shares outstanding basic and diluted (in shares)	4,868,079	3,337,351